Arformoterol
Names | |
---|---|
Trade names | Brovana |
Other names | Arformoterol tartrate |
| |
Clinical data | |
Drug class | LABA[1] |
Main uses | COPD[1] |
Side effects | Diarrhea, sinusitis, rash, peripheral swelling, chest pain[1] |
Routes of use | Inhalation solution for nebuliser |
External links | |
AHFS/Drugs.com | Monograph |
MedlinePlus | a602023 |
Legal | |
License data |
|
Legal status |
|
Pharmacokinetics | |
Protein binding | 52–65% |
Elimination half-life | 26 hours |
Chemical and physical data | |
Formula | C19H24N2O4 |
Molar mass | 344.411 g·mol−1 |
|
Arformoterol, sold under the brand name Brovana, is a medication used for the long-term treat chronic obstructive pulmonary disease (COPD).[1] It is not indicated for sudden worsening.[2] It is given by nebulization.[1] Maximum effect may take 3 hours.[1]
Common side effects include diarrhea, sinusitis, rash, peripheral swelling, and chest pain.[1] Other side effect ma include low potassium, anaphylaxis, and bronchospasm.[1] Safety in pregnancy is unclear.[1] It is a long-acting β2 adrenoreceptor agonist (LABA).[1] It is the active component of formoterol.[1]
Arformoterol was approved for medical use in the United States in 2006.[1] It is available as a generic medication.[3] In the United States a month of medication costs about 240 USD as of 2022.[3]
Medical uses
Dosage
It is typically used at a dose of 15 micrograms twice per day.[1]
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 "Arformoterol Monograph for Professionals". Drugs.com. Archived from the original on 25 January 2021. Retrieved 16 January 2022.
- ↑ "DailyMed - ARFORMOTEROL TARTRATE solution". dailymed.nlm.nih.gov. Archived from the original on 16 January 2022. Retrieved 16 January 2022.
- ↑ 3.0 3.1 "Arformoterol Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 14 August 2016. Retrieved 16 January 2022.
External links
External sites: | |
---|---|
Identifiers: |
|
- Pages using duplicate arguments in template calls
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Drugboxes which contain changes to verified fields
- Drugs not assigned an ATC code
- Articles with changed EBI identifier
- Beta2-adrenergic agonists
- Enantiopure drugs
- Phenol ethers
- Phenols
- Substituted amphetamines
- Formamides
- Phenylethanolamines
- All stub articles
- Respiratory system drug stubs